Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Thiamine-responsive megaloblastic anemia syndrome

MONDO:0009575

Thiamine-responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type I diabetes mellitus, and sensorineural deafness.

Also known as: Rogers syndrome, THMD1, TRMA, thiamine metabolism dysfunction syndrome 1, thiamine-responsive anemia syndrome, thiamine-responsive megaloblastic anemia syndrome, thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness, thiamine-responsive myelodysplasia

15 clinical trials for this condition and its sub-types, 6 tagged with Thiamine-responsive megaloblastic anemia syndrome itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →
Sort by